Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2008
DOI: 10.1055/s-2008-1027284
|View full text |Cite
|
Sign up to set email alerts
|

2007 Recommendations of the ICRP Change Basis for Estimation of the Effective Dose: What is the Impact on Radiation Dose Assessment of Patient and Personnel?

Abstract: The revision of the parameters for effective dose calculation leads to higher doses and greater sex-specific differences for radiological examinations involving exposure of the breast. This effect should be considered when justifying any radiological examination. For the personnel, the new model results in higher effective doses due to increased emphasis on the organs in the head and neck region. Hence to optimize radiation protection of personnel, the use of radiation-protective shielding for this region beco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0
4

Year Published

2008
2008
2019
2019

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 3 publications
(5 reference statements)
1
11
0
4
Order By: Relevance
“…This supports the derivation of two separate double dosimetry formulas for use and non-use of thyroid protection, respectively. This is in line with previous research determining E for angiography providing evidence for a factor of 1.7-3.0 (ICRP 1991) and 1.5-1.9 (ICRP 2007) for use vs. non-use of thyroid protection and severe limitations of the routine algorithm based on H p,c,u (10) at only one position according to ICRP 60 in this situation (von Boetticher et al 2008).…”
Section: Discussionsupporting
confidence: 90%
“…This supports the derivation of two separate double dosimetry formulas for use and non-use of thyroid protection, respectively. This is in line with previous research determining E for angiography providing evidence for a factor of 1.7-3.0 (ICRP 1991) and 1.5-1.9 (ICRP 2007) for use vs. non-use of thyroid protection and severe limitations of the routine algorithm based on H p,c,u (10) at only one position according to ICRP 60 in this situation (von Boetticher et al 2008).…”
Section: Discussionsupporting
confidence: 90%
“…In high-pitch CTCA, the femalespecific effective dose is higher compared to male effective dose measurements by an average of up to 8.6%. In conventional overlapping CTCA data acquisition, however, females received increased effective dose values of up to 70% [6,[12][13][14].…”
Section: Discussionmentioning
confidence: 99%
“…The breast phantom attachments could influence the calculation of the malespecific effective dose by increased soft tissue in the scan range. Nevertheless, evaluated values of effective dose using a hermaphrodite phantom are sufficiently precise for application in radiological radiation protection [5,6].…”
Section: Dosimetrymentioning
confidence: 99%
“…Dabei [20]. 2007 wurden modifizierte Organwichtungsfaktoren eingeführt [21], wobei hier für die CTC -im Gegensatz zu bspw. der Herz-CTBildgebung -durch die Neuberechnung der Wichtungsfaktoren keine wesentlich höheren effektiven Dosen zu erwarten sind.…”
Section: Auswertung Der Datensätzeunclassified